why choose us

Clinical Trials Search

Showing 18,600 of 132,963 result(s)
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Status: Completed

Condition: Metastatic Castration-resistant Prostate Cancer

Interventions: (177Lu)-PSMA-617 will be administered every 6 weeks for up to 6 cycles per SOC.
Oral Cabozantinib taken daily at home.

Date: 2022-11-04

Safety and Efficacy of Faricimab in Patients With NPDR

Status: Completed

Condition: Non-Proliferative Diabetic Retinopathy

Interventions: Faricimab is a humanized bispecific antibody binding to human Ang-2 and VEGF.
For Phase III studies, the Ro 686-7461 drug product is provided in

Date: 2022-11-04

Comparative Analysis of Virtuous and Autograft in Lumbar Fusion

Status: Completed

Condition: Degenerative Disc Disease

Interventions: Use of autograft or Virtuous Lyograft as an adjunct to spinal fusion in TLIF.

Date: 2022-11-04

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

Status: Completed

Condition: Childhood Idiopathic Nephrotic Syndrome

Interventions: Obinutuzumab will be administered as per schedule specified in the respective arm.

Date: 2022-11-04

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

Status: Completed

Condition: Locally Advanced Lung Non-Small Cell Carcinoma

Interventions: Given IV

Date: 2022-11-04

Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

Status: Completed

Condition: Non Small Cell Lung Cancer

Interventions: BMF-219 is an orally bioavailable, covalent small-molecule menin inhibitor.

Date: 2022-11-04

Neurofeedback During Eating for Bulimia Nervosa

Status: NOT_YET_RECRUITING

Condition: Bulimia Nervosa

Interventions: Participants will be instructed to use real-time fNIRS neurofeedback to non-invasively regulate neural activation associated with symptoms in individu

Date: 2022-11-04

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

Status: Completed

Condition: Non Small Cell Lung Cancer

Interventions: -Given 60 minutes (+;- 15 minutes) prior to docetaxel

Date: 2022-11-04

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Status: Completed

Condition: Deviated Nasal Septum

Interventions: A single injection into the pterygopalatine fossa bilaterally of 0.5% ropivacaine at a dose of 20 mg (each side)

Date: 2022-11-04

Differences Between Two Type Implants in Post-extraction Alveolus

Status: Completed

Condition: Dental Implants, Single-Tooth

Interventions: Interventional

Date: 2022-11-04